sodium;(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(CAS: 30034-03-8)

This compound is subject to the Globally Harmonized System (GHS) for classification and labeling of chemicals, REACH regulations in the EU for registration, evaluation, authorization, and restriction of chemicals, and FDA/EPA guidelines for its use in pharmaceuticals and environmental safety. Specific health and safety data sheets (SDS) and local regulations should also be consulted for detailed handling and storage requirements.

Alternative reagents like similar amino acid derivatives or tetrazole analogs can be used as substitutes. For instance, 5-amino-1-phenylpyrimidine-2,4(1H,3H)-dione or other structurally related compounds might serve as viable alternatives, depending on the specific reaction conditions and desired product.

The market for this compound shows steady growth, particularly in pharmaceutical and biotechnological applications. Research trends indicate increasing interest in its potential as an intermediate or active pharmaceutical ingredient (API) in drug development. Trends also suggest a rising demand for related compounds and their derivatives.

Waste containing this compound should be collected in appropriate containers and stored in a secure, well-ventilated area. Incineration or professional waste disposal services should be utilized for disposal. Environmental protection measures, including proper labeling and handling, should be strictly adhered to ensure compliance with local and international regulations.